Cost-effectiveness of capecitabine and bevacizumab maintenance treatment after first-line induction treatment in metastatic colorectal cancer
| Autor: | Franken, M.D., van Rooijen, E.M., May, A.M., Koffijberg, H., van Tinteren, H., Mol, L., ten Tije, A.J., Creemers, G.J., van der Velden, A.M.T., Tanis, B.C., Uyl-de Groot, C.A., Punt, C.J.A., Koopman, M., van Oijen, M.G.H. |
|---|---|
| Zdroj: | In European Journal of Cancer April 2017 75:204-212 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect